The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC | COM | 00287Y109 | 17,772 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| AMGEN INC | COM | 031162100 | 12,175 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| IGNYTA INC | COM | 451731103 | 626 | 46,721 | SH | SOLE | 46,721 | 0 | 0 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 307 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| ORACLE CORP | COM | 68389X105 | 18,265 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 17,309 | 220,780 | SH | SOLE | 220,780 | 0 | 0 | ||
| ZELTIQ AESTHETICS INC | COM | 98933Q108 | 460 | 16,119 | SH | SOLE | 16,119 | 0 | 0 | ||